Better Therapeutics

The announcement comes just weeks after the company reported it let go of approximately 35% of its workforce.

The company has let go of approximately 35% of its workforce.

The study will focus on Type 2 diabetes patients. 

Also: Better Therapeutics scored a $50 million loan facility, DiA Imaging Analysis raised $14 million and SCAN Group invested in MedArrive.

The deal is expected to close this summer, subject to stockholder approval, and will raise $113 million for the combined company.   

Also: uBiome's FBI investigation; Better Therapeutics' pivotal trial plans.

The daily-use digital intervention yielded "clinically meaningful" improvement in blood pressure among 172 users.

San Francisco-based FareWell is changing its name to Better Therapeutics, a rebranding that reflects the company’s shift in focus from weight loss and disease prevention to digital therapeutics to treat chronic diseases.